Method and system to remove soluble TNFR1,TNFR2, and IL2 in patients

Details for Australian Patent Application No. 2005240082 (hide)

Owner BioPheresis Technologies, Inc

Inventors Lentz, M. Rigdon

Agent FB Rice

Pub. Number AU-B-2005240082

PCT Pub. Number WO2005/107802

Priority 60/566,741 30.04.04 US

Filing date 29 April 2005

Wipo publication date 17 November 2005

Acceptance publication date 23 July 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61M 1/34 (2006.01) Suction or pumping devices for medical purposes - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/107802 Priority application(s): WO2005/107802

7 December 2006 Change of Name(s) of Applicant(s), Section 104

  BioPheresis Technologies, LLC The name of the applicant has been changed to BioPheresis Technologies, Inc

23 July 2009 Application Accepted

  Published as AU-B-2005240082

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240087-Electric cooking apparatus having removable heating plates and method for using same

2005240081-Anti-excitotoxic sustained release intraocular implants and related methods